In PAH patients undergoing right heart catheterization (NCT01457170, N = 19), this apelin analog reduced pulmonary vascular resistance and increased cardiac output without reducing mean pulmonary arterial pressure (126). Here, APLN is linked to pulmonary arterial hypertension.